Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ.

Circulation. 1997 Jul 15;96(2):404-7.

4.

Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.

Hillis GS, Pearson CV, Harding SA, Sutherland S, Ludlam CA, Marioni JC, Prescott RJ, Fox KA, Flapan AD.

Am Heart J. 2004 Jul;148(1):72-9.

PMID:
15215794
5.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.

Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson C.

Circulation. 2000 Oct 10;102(15):1755-60.

6.

High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.

Jafarzadeh A, Esmaeeli-Nadimi A, Shariati M.

Iran J Immunol. 2008 Mar;5(1):51-6. doi: IJIv5i1A5.

PMID:
18319525
7.

[Chlamydia pneumoniae and Helicobacter pylori infections in acute myocardial infarction].

Di Tano G, Picerno I, Calisto ML, Delia SA, Lagana P, Spataro P.

Ital Heart J Suppl. 2000 Dec;1(12):1576-81. Italian.

PMID:
11221586
8.

Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.

Burkhardt U, Zahn R, Höffler U, Siegler KE, Frilling B, Weber M, Gottwik M, Wehr M, Seidel F, Rosocha S, Tebbe U, Senges J.

Z Kardiol. 2004 Sep;93(9):671-8.

PMID:
15365734
9.

Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.

Gattone M, Iacoviello L, Colombo M, Castelnuovo AD, Soffiantino F, Gramoni A, Picco D, Benedetta M, Giannuzzi P.

Am Heart J. 2001 Oct;142(4):633-40.

PMID:
11579353
10.

Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.

Vainas T, Stassen FR, Schurink GW, Tordoir JH, Welten RJ, van den Akker LH, Kurvers HA, Bruggeman CA, Kitslaar PJ.

Eur J Vasc Endovasc Surg. 2005 Apr;29(4):403-11.

11.

Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction.

Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH.

Circulation. 1999 Mar 9;99(9):1161-4.

12.

Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study.

Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Psaty BM, Tracy RP, Kuller LH, Kronmal RA.

Circulation. 2000 Nov 7;102(19):2335-40.

13.
14.
15.

Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.

Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B.

Circulation. 2004 Mar 2;109(8):1010-5. Epub 2004 Feb 9.

16.

Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease.

Heltai K, Kis Z, Burian K, Endresz V, Veres A, Ludwig E, Gönczöl E, Valyi-Nagy I.

Atherosclerosis. 2004 Apr;173(2):339-46.

PMID:
15064111
18.
19.

Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease.

Jackson LA, Stewart DK, Wang SP, Cooke DB, Cantrell T, Grayston JT.

J Antimicrob Chemother. 1999 Sep;44(3):411-4.

PMID:
10511413
20.

Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.

Zairis MN, Papadaki OA, Psarogianni PK, Thoma MA, Andrikopoulos GK, Batika PC, Poulopoulou CG, Trifinopoulou KG, Olympios CD, Foussas SG.

Am Heart J. 2003 Dec;146(6):1082-9.

PMID:
14661003

Supplemental Content

Support Center